200 related articles for article (PubMed ID: 14647046)
21. Bilirubin response to corticosteroids in severe alcoholic hepatitis.
Morris JM; Forrest EH
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):759-62. PubMed ID: 15947554
[TBL] [Abstract][Full Text] [Related]
22. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.
Forrest EH; Evans CD; Stewart S; Phillips M; Oo YH; McAvoy NC; Fisher NC; Singhal S; Brind A; Haydon G; O'Grady J; Day CP; Hayes PC; Murray LS; Morris AJ
Gut; 2005 Aug; 54(8):1174-9. PubMed ID: 16009691
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
[TBL] [Abstract][Full Text] [Related]
24. The management of alcoholic hepatitis: a prospective comparison of scoring systems.
Lafferty H; Stanley AJ; Forrest EH
Aliment Pharmacol Ther; 2013 Sep; 38(6):603-10. PubMed ID: 23879668
[TBL] [Abstract][Full Text] [Related]
25. [The efficacy of two type of membrane plasma separator on the treatment of patients with chronic severe hepatitis B].
Zhang DZ; Zhao YR; Zhang QH; Wang ZY; Qin B; He H; Zhou Z; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):208-9. PubMed ID: 15099467
[TBL] [Abstract][Full Text] [Related]
26. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
[TBL] [Abstract][Full Text] [Related]
27. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
Mathurin P; Mendenhall CL; Carithers RL; Ramond MJ; Maddrey WC; Garstide P; Rueff B; Naveau S; Chaput JC; Poynard T
J Hepatol; 2002 Apr; 36(4):480-7. PubMed ID: 11943418
[TBL] [Abstract][Full Text] [Related]
28. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.
Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS
Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125
[TBL] [Abstract][Full Text] [Related]
29. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes.
Mathurin P
Liver Transpl; 2005 Nov; (11 Suppl 2):S21-4. PubMed ID: 16237730
[TBL] [Abstract][Full Text] [Related]
30. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
31. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial.
Phillips M; Curtis H; Portmann B; Donaldson N; Bomford A; O'Grady J
J Hepatol; 2006 Apr; 44(4):784-90. PubMed ID: 16469404
[TBL] [Abstract][Full Text] [Related]
32. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone.
Mendenhall CL; Anderson S; Garcia-Pont P; Goldberg S; Kiernan T; Seeff LB; Sorrell M; Tamburro C; Weesner R; Zetterman R
N Engl J Med; 1984 Dec; 311(23):1464-70. PubMed ID: 6390194
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of prognostic factors of and to establish a predictive model for patients with chronic severe hepatitis].
Zhang N; Wang YM; Deng GH; Yi D
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):730-3. PubMed ID: 16248942
[TBL] [Abstract][Full Text] [Related]
34. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.
Naveau S; Chollet-Martin S; Dharancy S; Mathurin P; Jouet P; Piquet MA; Davion T; Oberti F; Broët P; Emilie D;
Hepatology; 2004 May; 39(5):1390-7. PubMed ID: 15122768
[TBL] [Abstract][Full Text] [Related]
35. MELD accurately predicts mortality in patients with alcoholic hepatitis.
Dunn W; Jamil LH; Brown LS; Wiesner RH; Kim WR; Menon KV; Malinchoc M; Kamath PS; Shah V
Hepatology; 2005 Feb; 41(2):353-8. PubMed ID: 15660383
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
[TBL] [Abstract][Full Text] [Related]
37. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.
Srikureja W; Kyulo NL; Runyon BA; Hu KQ
J Hepatol; 2005 May; 42(5):700-6. PubMed ID: 15826720
[TBL] [Abstract][Full Text] [Related]
38. Early predictors of success of Kasai operation in children with biliary atresia.
Rodeck B; Becker AC; Gratz KF; Petersen C
Eur J Pediatr Surg; 2007 Oct; 17(5):308-12. PubMed ID: 17968785
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.
Rudler M; Mouri S; Charlotte F; Lebray P; Capocci R; Benosman H; Poynard T; Thabut D
J Hepatol; 2015 Apr; 62(4):816-21. PubMed ID: 25450199
[TBL] [Abstract][Full Text] [Related]
40. Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series.
Morris JM; Dickson S; Neilson M; Hodgins P; Forrest EH
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):457-60. PubMed ID: 19855284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
